Chronic UV radiation-induced RORγt+ IL-22-producing lymphoid cells are associated with mutant KC clonal expansion
- PMID: 34504008
- PMCID: PMC8449378
- DOI: 10.1073/pnas.2016963118
Chronic UV radiation-induced RORγt+ IL-22-producing lymphoid cells are associated with mutant KC clonal expansion
Abstract
Chronic ultraviolet (UV) radiation exposure is the greatest risk factor for cutaneous squamous cell carcinoma (cSCC) development, and compromised immunity accelerates this risk. Having previously identified that epidermal Langerhans cells (LC) facilitate the expansion of UV-induced mutant keratinocytes (KC), we sought to more fully elucidate the immune pathways critical to cutaneous carcinogenesis and to identify potential targets of intervention. Herein, we reveal that chronic UV induces and LC enhance a local immune shift toward RORγt+ interleukin (IL)-22/IL-17A-producing cells that occurs in the presence or absence of T cells while identifying a distinct RORγt+ Sca-1+ CD103+ ICOS+ CD2+/- CCR6+ intracellular CD3+ cutaneous innate lymphoid cell type-3 (ILC3) population (uvILC3) that is associated with UV-induced mutant KC growth. We further show that mutant KC clone size is markedly reduced in the absence of RORγt+ lymphocytes or IL-22, both observed in association with expanding KC clones, and find that topical application of a RORγ/γt inhibitor during chronic UV exposure reduces local expression of IL-22 and IL-17A while markedly limiting mutant p53 KC clonal expansion. We implicate upstream Toll-like receptor signaling in driving this immune response to chronic UV exposure, as MyD88/Trif double-deficient mice also show substantially reduced p53 island number and size. These data elucidate key immune components of chronic UV-induced cutaneous carcinogenesis that might represent targets for skin cancer prevention.
Keywords: TP53; carcinogenesis; innate lymphoid cells; interleukin-22; squamous cell carcinoma.
Conflict of interest statement
The authors declare no competing interest.
Figures
![Fig. 1.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/8449378/bin/pnas.2016963118fig01.gif)
![Fig. 2.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/8449378/bin/pnas.2016963118fig02.gif)
![Fig. 3.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/8449378/bin/pnas.2016963118fig03.gif)
![Fig. 4.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/8449378/bin/pnas.2016963118fig04.gif)
![Fig. 5.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/8449378/bin/pnas.2016963118fig05.gif)
![Fig. 6.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/8449378/bin/pnas.2016963118fig06.gif)
![Fig. 7.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/8449378/bin/pnas.2016963118fig07.gif)
Similar articles
-
Langerhans Cells Facilitate UVB-Induced Epidermal Carcinogenesis.J Invest Dermatol. 2015 Nov;135(11):2824-2833. doi: 10.1038/jid.2015.207. Epub 2015 Jun 8. J Invest Dermatol. 2015. PMID: 26053049 Free PMC article.
-
A T-bet gradient controls the fate and function of CCR6-RORγt+ innate lymphoid cells.Nature. 2013 Feb 14;494(7436):261-5. doi: 10.1038/nature11813. Epub 2013 Jan 16. Nature. 2013. PMID: 23334414
-
Cross-talk between RORγt+ innate lymphoid cells and intestinal macrophages induces mucosal IL-22 production in Crohn's disease.Inflamm Bowel Dis. 2014 Aug;20(8):1426-34. doi: 10.1097/MIB.0000000000000105. Inflamm Bowel Dis. 2014. PMID: 24991784
-
UV-Induced Molecular Signaling Differences in Melanoma and Non-melanoma Skin Cancer.Adv Exp Med Biol. 2017;996:27-40. doi: 10.1007/978-3-319-56017-5_3. Adv Exp Med Biol. 2017. PMID: 29124688 Review.
-
Development and regulation of RORγt(+) innate lymphoid cells.FEBS Lett. 2014 Nov 17;588(22):4176-81. doi: 10.1016/j.febslet.2014.03.034. Epub 2014 Mar 26. FEBS Lett. 2014. PMID: 24681095 Review.
Cited by
-
Understanding Type 3 Innate Lymphoid Cells and Crosstalk with the Microbiota: A Skin Connection.Int J Mol Sci. 2024 Feb 7;25(4):2021. doi: 10.3390/ijms25042021. Int J Mol Sci. 2024. PMID: 38396697 Free PMC article. Review.
-
ILC3: a case of conflicted identity.Front Immunol. 2023 Oct 17;14:1271699. doi: 10.3389/fimmu.2023.1271699. eCollection 2023. Front Immunol. 2023. PMID: 37915588 Free PMC article. Review.
-
The Roles of Skin Langerhans Cells in Immune Tolerance and Cancer Immunity.Vaccines (Basel). 2022 Aug 24;10(9):1380. doi: 10.3390/vaccines10091380. Vaccines (Basel). 2022. PMID: 36146458 Free PMC article. Review.
-
Innate lymphoid cells in early tumor development.Front Immunol. 2022 Aug 12;13:948358. doi: 10.3389/fimmu.2022.948358. eCollection 2022. Front Immunol. 2022. PMID: 36032129 Free PMC article. Review.
-
Tissue-Specific Diversity of Group 2 Innate Lymphoid Cells in the Skin.Front Immunol. 2022 Jun 9;13:885642. doi: 10.3389/fimmu.2022.885642. eCollection 2022. Front Immunol. 2022. PMID: 35757747 Free PMC article. Review.
References
-
- Galiczynski E. M., Vidimos A. T., Nonsurgical treatment of nonmelanoma skin cancer. Dermatol. Clin. 29, 297–309 (2011). - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous